T. Rowe Price Associates
VSTM icon

T. Rowe Price Associates’s Verastem VSTM Stock Holding History

T. Rowe Price Associates’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Buy
65,565
+18,738
+40% +$90.7K ﹤0.01% 2922
2026
Q1 		$249K Buy
46,827
+19,591
+72% +$121K ﹤0.01% 2760
2025
Q4 		$211K Sell
27,236
-550,796
-95% -$4.91M ﹤0.01% 2788
2025
Q3 		$5.11M Buy
578,032
+555,377
+2,451% +$4.13M ﹤0.01% 1383
2025
Q2 		$95K Buy
22,655
+4,603
+25% +$28.8K ﹤0.01% 2904
2025
Q1 		$109K Buy
18,052
+2,662
+17% +$16.3K ﹤0.01% 2804
2024
Q4 		$80K Buy
15,390
+129
+0.8% +$508 ﹤0.01% 2877
2024
Q3 		$46K Buy
+15,261
New +$41.4K ﹤0.01% 2939
2022
Q2 		– Sell
-1,260
Closed -$21K – 3017
2022
Q1 		$21K Buy
1,260
+308
+32% +$5.3K ﹤0.01% 2957
2021
Q4 		$23K Sell
952
-241
-20% -$7.61K ﹤0.01% 2956
2021
Q3 		$44K Buy
1,193
+41
+4% +$1.51K ﹤0.01% 2909
2021
Q2 		$56K Buy
1,152
+168
+17% +$7K ﹤0.01% 2893
2021
Q1 		$29K Buy
984
+2
+0.2% +$56 ﹤0.01% 2836
2020
Q4 		$25K Hold
982
– – ﹤0.01% 2659
2020
Q3 		$14K Sell
982
-86,700
-99% -$1.43M ﹤0.01% 2588
2020
Q2 		$1.81M Buy
+87,682
New +$2.32M ﹤0.01% 1560
2020
Q1 		– Sell
-27,450
Closed -$441K – 2564
2019
Q4 		$441K Buy
27,450
+5,925
+28% +$85.2K ﹤0.01% 2192
2019
Q3 		$313K Hold
21,525
– – ﹤0.01% 2267
2019
Q2 		$390K Buy
21,525
+17,731
+467% +$402K ﹤0.01% 2212
2019
Q1 		$135K Buy
3,794
+17
+0.5% +$672 ﹤0.01% 2445
2018
Q4 		$152K Buy
3,777
+9
+0.2% +$549 ﹤0.01% 2450
2018
Q3 		$328K Buy
3,768
+1,102
+41% +$110K ﹤0.01% 2327
2018
Q2 		$220K Sell
2,666
-1,276
-32% -$78.1K ﹤0.01% 2433
2018
Q1 		$141K Sell
3,942
-5,108
-56% -$198K ﹤0.01% 2461
2017
Q4 		$333K Buy
+9,050
New +$409K ﹤0.01% 2243

Other funds holding VSTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates's VSTM Position: Q2 2026 in Review

T. Rowe Price Associates increased its Verastem (VSTM) stake by 40% in Q2 2026, buying an estimated $90.7K and bringing the position to 65,565 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #2922.

T. Rowe Price Associates first reported a position in VSTM in Q4 2017 and has held it in 25 quarters since. The position peaked at $5.11M in Q3 2025. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • T. Rowe Price Associates held 65,565 shares of Verastem worth $251K as of Q2 2026.
  • T. Rowe Price Associates bought 18,738 Verastem shares in Q2 2026, an estimated $90.7K.
  • Verastem made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2922 holding.
  • T. Rowe Price Associates first reported a position in Verastem in Q4 2017 and has held it in 25 quarters since.
  • T. Rowe Price Associates's Verastem position peaked at $5.11M in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.